| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
31,530 |
24,957 |
$1.04M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
24,236 |
18,878 |
$711K |
| 94760 |
|
30,854 |
21,303 |
$87K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,268 |
958 |
$68K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
8,334 |
6,487 |
$47K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
9,097 |
7,846 |
$26K |
| 94681 |
|
826 |
804 |
$18K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,754 |
1,656 |
$15K |
| 20610 |
|
1,518 |
1,114 |
$14K |
| 94375 |
|
816 |
793 |
$13K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
173 |
141 |
$11K |
| 36415 |
Collection of venous blood by venipuncture |
12,565 |
10,712 |
$11K |
| 81000 |
|
7,875 |
6,815 |
$10K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,634 |
4,066 |
$10K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,256 |
1,138 |
$10K |
| 99215 |
Prolong outpt/office vis |
186 |
169 |
$10K |
| 94200 |
|
826 |
804 |
$9K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
846 |
675 |
$8K |
| 86403 |
|
856 |
832 |
$7K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
436 |
391 |
$7K |
| 71046 |
Radiologic examination, chest; 2 views |
642 |
590 |
$6K |
| 80305 |
|
2,449 |
2,275 |
$6K |
| 90686 |
|
1,315 |
1,150 |
$6K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
315 |
229 |
$6K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
857 |
656 |
$6K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
344 |
336 |
$5K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
1,286 |
984 |
$4K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
1,760 |
1,657 |
$4K |
| 99407 |
|
680 |
529 |
$4K |
| 76770 |
|
69 |
68 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,517 |
3,687 |
$3K |
| 1125F |
|
15,660 |
12,556 |
$2K |
| 90674 |
|
176 |
171 |
$2K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
21 |
15 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
20 |
19 |
$1K |
| 3075F |
|
5,548 |
4,334 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
5,391 |
4,326 |
$1K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
28 |
28 |
$1K |
| 93000 |
|
177 |
170 |
$1K |
| 87400 |
|
98 |
78 |
$984.07 |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
12 |
12 |
$802.64 |
| 90756 |
|
69 |
67 |
$752.07 |
| 72100 |
|
39 |
38 |
$701.25 |
| 3074F |
|
11,257 |
8,228 |
$652.75 |
| 94664 |
|
99 |
97 |
$613.25 |
| 76536 |
|
12 |
12 |
$571.74 |
| 99354 |
|
14 |
13 |
$469.64 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
719 |
552 |
$445.13 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
34 |
17 |
$384.80 |
| 73560 |
|
25 |
25 |
$361.91 |
| 99406 |
|
91 |
90 |
$353.77 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
330 |
270 |
$260.45 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
1,557 |
1,202 |
$230.62 |
| 83880 |
|
18 |
16 |
$211.98 |
| 99497 |
|
333 |
269 |
$211.62 |
| 96127 |
|
178 |
176 |
$197.87 |
| 3077F |
|
6,355 |
4,883 |
$189.43 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
234 |
175 |
$153.57 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
590 |
481 |
$146.80 |
| 85610 |
|
273 |
196 |
$126.62 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
163 |
135 |
$104.00 |
| 3044F |
|
1,017 |
861 |
$71.22 |
| 99080 |
|
365 |
315 |
$69.68 |
| 84484 |
|
18 |
16 |
$67.32 |
| 85379 |
|
18 |
16 |
$61.08 |
| G0008 |
Administration of influenza virus vaccine |
1,039 |
936 |
$55.03 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
41 |
29 |
$46.20 |
| 3078F |
|
9,896 |
7,466 |
$43.74 |
| 90656 |
|
12 |
12 |
$33.44 |
| 94761 |
|
18 |
17 |
$32.42 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
274 |
143 |
$26.97 |
| 3079F |
|
10,619 |
7,868 |
$24.07 |
| 82553 |
|
18 |
16 |
$23.10 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
1,980 |
1,541 |
$19.30 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
93 |
86 |
$9.48 |
| 96160 |
|
40 |
36 |
$8.28 |
| G9744 |
Patient not eligible due to active diagnosis of hypertension |
24 |
24 |
$0.00 |
| 1159F |
|
80 |
78 |
$0.00 |
| 3045F |
|
14 |
14 |
$0.00 |
| 3288F |
|
267 |
259 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
811 |
670 |
$0.00 |
| 1160F |
|
68 |
66 |
$0.00 |
| 1124F |
|
27 |
27 |
$0.00 |
| G9991 |
Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period |
33 |
27 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
39 |
36 |
$0.00 |
| 4040F |
|
142 |
111 |
$0.00 |
| 4013F |
|
285 |
248 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
29 |
29 |
$0.00 |
| 1100F |
|
32 |
30 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
29 |
29 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
41 |
36 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
33 |
26 |
$0.00 |
| 0521F |
|
34 |
31 |
$0.00 |
| G9899 |
Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed |
18 |
15 |
$0.00 |
| 99442 |
|
44 |
23 |
$0.00 |
| 3080F |
|
2,446 |
1,983 |
$0.00 |
| 3017F |
|
114 |
94 |
$0.00 |
| 1170F |
|
422 |
409 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
67 |
65 |
$0.00 |
| 1123F |
|
188 |
150 |
$0.00 |
| 99000 |
|
267 |
217 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
61 |
59 |
$0.00 |
| 4010F |
|
213 |
209 |
$0.00 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
205 |
98 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
93 |
92 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
35 |
35 |
$0.00 |
| 1111F |
|
113 |
97 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
117 |
103 |
$0.00 |
| 1126F |
|
82 |
71 |
$0.00 |
| J3304 |
Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg |
49 |
42 |
$0.00 |
| 1006F |
|
63 |
63 |
$0.00 |
| 3008F |
|
15 |
15 |
$0.00 |